18 related articles for article (PubMed ID: 6257529)
1. Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes.
Kelso EJ; McDermott BJ; Silke B
Br J Pharmacol; 1993 Dec; 110(4):1387-94. PubMed ID: 8306078
[TBL] [Abstract][Full Text] [Related]
2. Effects of nifedipine derivatives on smooth muscle cells and neuromuscular transmission in the rabbit mesenteric artery.
Makita Y; Kanmura Y; Itoh T; Suzuki H; Kuriyama H
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):302-12. PubMed ID: 6320018
[TBL] [Abstract][Full Text] [Related]
3. Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Sorkin EM; Clissold SP
Drugs; 1987 Apr; 33(4):296-345. PubMed ID: 3297616
[TBL] [Abstract][Full Text] [Related]
4. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
Ishii K; Taira N; Yanagisawa T
Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
Satoh K; Yanagisawa T; Taira N
Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
Sakamoto N; Terai M; Takenaka T; Maeno H
Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
[No Abstract] [Full Text] [Related]
7. A possible mechanism for relaxation of rat uterine smooth muscle by nicardipine hydrochloride (YC-93), a new potent vasodilator.
Nishikori K; Takenaka T; Maeno H
Jpn J Pharmacol; 1981 Oct; 31(5):701-9. PubMed ID: 6273630
[TBL] [Abstract][Full Text] [Related]
8. The time course of the effects of beta- and alpha-adrenoceptor stimulation by isoprenaline and methoxamine on the contractile force and cAMP level of the isolated rabbit papillary muscle.
Schümann HJ; Endoh S; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):291-302. PubMed ID: 169486
[TBL] [Abstract][Full Text] [Related]
9. Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism.
Endoh M
Basic Res Cardiol; 1989; 84 Suppl 1():69-83. PubMed ID: 2554874
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of cyclic AMP and contractile responses to isoprenaline: effects of a dihydropyridine derivative, nicardipine (YC-93), on canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N
Eur J Pharmacol; 1980 Oct; 67(2-3):225-33. PubMed ID: 6257529
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
